Table 4 HLA-A*02 status IHC and HLA-A... | American Society of Hematology

Table 4

HLA-A*02 status

IHC and HLA-A*02–specific PCR	EBV⁺ HL	Control participants	EBV⁻ HL	P, EBV⁺ HL versus
IHC and HLA-A*02–specific PCR	EBV⁺ HL	Control participants	EBV⁻ HL	Control	EBV⁻ HL
No. patients	152	6107	322	—	—
HLA-A*02⁺	35.5%	53.0%	50.9%	< .001	.001

IHC and HLA-A*02–specific PCR	EBV⁺ HL	Control participants	EBV⁻ HL	P, EBV⁺ HL versus
IHC and HLA-A*02–specific PCR	EBV⁺ HL	Control participants	EBV⁻ HL	Control	EBV⁻ HL
No. patients	152	6107	322	—	—
HLA-A*02⁺	35.5%	53.0%	50.9%	< .001	.001

— indicates not applicable.